Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

FDA's Fast-Track for Rexulti Raises Concerns

CMS efforts to reduce use of unnecessary antipsychotics in nursing homes may conflict with marketing efforts for the drug.

Rexulti
Rexulti

According to a recent SciTechDaily article, the FDA's questionable fast-tracking of the antipsychotic drug Rexulti. The drug intended for elderly dementia patients has raised concerns about the approval process and influence of commercial interests on patient advocacy groups. Despite limited clinical benefits and an increased mortality risk, Rexulti received approval for treating agitation in elderly dementia patients. The drug's manufacturers, Otsuka and Lundbeck, anticipate large profits, but journalists raise questions about the drug's harm-benefit balance. The FDA's decision may also undermine years of efforts by the CMS to reduce off-label use of antipsychotics in residential care homes.

List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
List: Digitalization Companies From PACK EXPO
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?